Araştırma Makalesi
BibTex RIS Kaynak Göster

Dupuytren Kontraktürü: Parsiyel Fasiektomi Uygulanan 32 Hastanın Retrospektif Analizi

Yıl 2019, , 119 - 123, 01.08.2019
https://doi.org/10.32708/uutfd.506471

Öz

Dupuytren kontraktürü nedeniyle parsiyel fasiektomi uyguladığımız
32 hastanın demografik ve klinik özellikleri, fonksiyonel sonuçları,
komplikasyon ve nüks oranları güncel literatür eşliğinde tartışıldı.
Çalışmamızda; erkek/kadın oranı: 7/1, hastalığın başlangıcındaki ortalama yaş
55.4±7.1, cerrahi esnasındaki ortalama yaş 60.4±8.1 olarak tespit edildi. 7
hastada (%21.875) aile öyküsü, 22 hastada (%68.75) sigara kullanımı, 6 hastada
(%18,75) düzenli alkol kullanımı, 10 hastada (%31,25) tip 2 diyabet, 2 hastada
(%6.25) karaciğer hastalığı, 1 hastada (%3.125) epilepsiye bağlı uzun süre
barbitürat kullanımı gibi etiyolojik faktörler mevcuttu. En sık etkilenen
parmak 26 hasta (%81.25) ile yüzük parmağı olup, 18 hastada (%56.25) küçük
parmak, 8 hastada (%25) orta parmak, 1 hastada (%3.125) işaret parmağı tutulumu
vardı. Ameliyat öncesi, ortalama total pasif ekstansiyon kaybı (TPEK)
89.68º±30.29, ameliyat sonrası ortalama TPEK 6.09º±6.44 olarak bulundu.
Ameliyat sonrası ortalama total ekstansiyon kazancı %93.2 olarak bulundu.
Ortalama takip süresi 70±44 ay olup, bu süre içerisinde 1 hastada (%3.125) nüks
görüldü. 2 hastada pansumanlara sekonder iyileşen cilt nekrozu, 1 hastada
geçici hipoestezi olmak üzere toplam 3 hastada (%9.375) komplikasyon meydana
geldi. MKF ve PİP eklem kontraktüründe yeterli düzelme sağlaması, komplikasyon
ve nüks oranlarının düşük olması nedeniyle parsiyel fasiektomi dupuytren
kontraktürünün cerrahi tedavisinde etkili ve güvenilir bir yöntemdir.

Kaynakça

  • 1. Thurston A. Dupuytren's disease or Cooper's contracture? Kenneth Fitzpatrick Russell Memorial Lecture. ANZ J Surg 2003;73(7):529-35.
  • 2. Townley WA, Baker R, Sheppard N, Grobbelaar AO. Dupuytren's contracture unfolded. BMJ 2006;332(7538):397-400.
  • 3. Hindocha S. Risk Factors, Disease Associations, and Dupuytren Diathesis. Hand Clin 2018;34(3):307-14
  • 4. Rayan GM. Clinical presentation and types of Dupuytren’s disease. Hand Clinic 1999;15(1):87-96.
  • 5. Geoghegan JM, Forbes J, Clark DI, Smith C, Hubbard R. Dupuytren's disease risk factors. J Hand Surg Br 2004;29(5):423-6.
  • 6. Luck JV. Dupuytren's contracture; a new concept of the pathogenesis correlated with surgical management. J Bone Joint Surg Am 1959:41(4):635-64.
  • 7. Tubiana R. Evaluation of deformities in Dupuytren’s disease. Ann Chir Main 1986;5(1):5-11.
  • 8. McGrouther DA. Dupuytren’s contracture. In: Green’s operative hand surgery. 6th ed. Philadelphia: Elsevier; 2005.159-85.
  • 9. Smith AC. Diagnosis and indications for surgical treatment. Hand Clin. 1991;7(4):635-42.
  • 10. Crean SM, Gerber RA, Graverand MP, Boyd DM, Cappelleri JC. The efficacy and safety of fasciectomy and fasciotomy for Dupuytren’s contracture in European patients: a structured review of published studies. J Hand Surg Eur 2011;36(5):396-407.
  • 11. Desai SS, Hentz VR. The treatment of Dupuytren disease. J Hand Surg Am 2011; 36(5):936-42.
  • 12. Eaton C. Percutaneous fasciotomy for Dupuytren’s contracture. J Hand Surg Am 2011;36(5):910-5.
  • 13. Becker GW, Davis TR. The outcome of surgical treatments for primary Dupuytren’s disease-a systematic review. J Hand Surg Eur 2010;35(8):623-6.
  • 14. Au-Yong IT, Wildin CJ, Dias JJ, Page RE. A review of common practice in Dupuytren surgery. Tech Hand Up Extrem Surg 2005;9(4):178-87.
  • 15. van Rijssen AL, Werker PM. Percutaneous needle fasciotomy in dupuytren's disease. J Hand Surg Br 2006;31(5):498-501.
  • 16. Wilson GR. Current surgical treatment of Dupuytren’s disease. Br J Clin Pract 1997;51(2):106-10.
  • 17. Bryan AS, Ghorbal MS. The long-term results of closed palmar fasciotomy in the management of Dupuytren’s contracture. J Hand Surg Br 1988;13(3):254-6.
  • 18. Foucher G, Medina J, Navarro R. Percutaneous needle aponeurotomy: complications and results. J Hand Surg Br 2003;28(5):427-31.
  • 19. Coert JH, Nérin JP, Meek MF. Results of partial fasciectomy for Dupuytren disease in 261 consecutive patients. Ann Plast Surg 2006;57(1):13-7.
  • 20. Werker PM, Pess GM, van Rijssen AL, Denkler K. Correction of contracture and recurrence rates of Dupuytren contracture following invasive treatment: the importance of clear definitions. J Hand Surg Am 2012;37(10):2095-105.
  • 21. Dias JJ, Braybrooke J. Dupuytren’s contracture: an audit of the outcomes of surgery. J Hand Surg Br 2006;31(5):514-21.
  • 22. Dias JJ, Singh HP, Ullah A, Bhowal B, Thompson JR. Patterns of recontracture after surgical correction of Dupuytren disease. J Hand Surg Am 2013;38(10):1987-93.
  • 23. Tonkin MA, Burke FD, Varian JPW. Dupuytren’s contracture: a comparative study of fasciectomy and dermofasciectomy in one hundred patients. J Hand Surg Br 1984;9(2):156-62.
  • 24. Mäkelä EA, Jaroma H, Harju A, Anttila S, Vainio J. Dupuytren’s contracture: the long-term results after day surgery. J Hand Surg Br 1991;16(3):272-4.
  • 25. Anwar MU, Al Ghazal SK, Boome RS. Results of surgical treatment of Dupuytren’s disease in women: a review of 109 consecutive patients. J Hand Surg Am 2007;32(9):1423-8.
  • 26. Kitridis D, Karamitsou P, Giannaros I, Papadakis N, Sinopidis C, Givissis P. Dupuytren’s disease: limited fasciectomy, night splinting, and hand exercises-long-term results. Eur J Orthop Surg Traumatol 2018;doi:10.1007/s00590-018-2340-6. [Epub ahead of print]
  • 27. Dias JJ, Aziz S. Fasciectomy for Dupuytren Contracture. Hand Clin 2018;34(3):351-66.
  • 28. van Rijssen AL, Gerbrandy FS, Ter Linden H, Klip H, Werker PM. A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren’s disease: a 6-week followup study. J Hand Surg Am 2006;31(5):717-25.
  • 29. Chen NC, Srinivasan RC, Shauver MJ, Chung KC. A systematic review of outcomes of fasciotomy, aponeurotomy, and collagenase treatments for Dupuytren’s contracture. Hand 2011;6(3):250-5.
  • 30. Bryan AS, Ghorbal MS. The long-term results of closed palmar fasciotomy in the management of Dupuytren’s contracture. J Hand Surg Br 1998;13(3):254-6.
  • 31. Moermans JP. Long-term results after segmental aponeurectomy for Dupuytren’s disease. J Hand Surg Br 1996;21(6):797-800.
  • 32. Clibbon JJ, Logan AM. Palmar segmental aponeurectomy for Dupuytren’s disease with metacarpophalangeal fexion contracture. J Hand Surg Br 2001;26(4):360-1.
  • 33. Armstrong JR, Hurren JS, Logan AM. Dermofasciectomy in the management of Dupuytren’s disease. J Bone Joint Surg Br 2000;82(1):90-4.
  • 34. Abbott K, Denney J, Burke FD, McGrouther DA. A review of attitudes to splintage in Dupuytren’s contracture. J Hand Surg Br 1987;12(3):326-8.

Dupuyten’ s Contracture: Retrospective Analysis of 32 Patients Operated by Partial Fasciectomy

Yıl 2019, , 119 - 123, 01.08.2019
https://doi.org/10.32708/uutfd.506471

Öz

Demographic and clinical features of 32 patients
diagnosed with dupuytren contracture and operated by partial fasciectomy were
included in this study.  Functional
results, complications and recurrence rates were discussed with current
literature. In our study male/female ratio was 7/1, mean age at onset of
disease was 55.4±7.1, mean age at surgery was 60.4±8.1. There were etiological
factors such as a family history in 7 patients (21.875%), smoking in 22
patients (68.75%), regular alcohol use in 6 patients  (%18,75), type 2 diabetes in 10 patients
(31.25%), hepatic disease in 2 patients (6.25%), long term barbiturate use for
epilepsy in 1 patients (3.125%). The most often involved finger was the ring
finger in 26 patients (81.25%), the small finger in 18 patients  (56.25%), middle finger in 8 patients (25%)
and index finger in 1 patient (3.125%). The pre-operative mean total passive
extension deficit (TPEK) was 89.68º ± 30.29, the post-operative mean TPED was
6.09º ± 6.44. The post-operative mean total extension gain was 93.2%. The mean follow-up was 70±44 months, 1 patient (3.125%)
had a recurrence in this period. The overall complications occured in 3
patients (9.375%), including skin necrosis in 2 patients (treated with
dressings) and temporary hypoesthesia in 1 patient. The partial faciectomy is
an effective and reliable method for the surgical treatment of dupuyren
contracture because of improvement enough correction in the MCF and PIP joint
contracture, the low rate of complication and recurrence rates.

Kaynakça

  • 1. Thurston A. Dupuytren's disease or Cooper's contracture? Kenneth Fitzpatrick Russell Memorial Lecture. ANZ J Surg 2003;73(7):529-35.
  • 2. Townley WA, Baker R, Sheppard N, Grobbelaar AO. Dupuytren's contracture unfolded. BMJ 2006;332(7538):397-400.
  • 3. Hindocha S. Risk Factors, Disease Associations, and Dupuytren Diathesis. Hand Clin 2018;34(3):307-14
  • 4. Rayan GM. Clinical presentation and types of Dupuytren’s disease. Hand Clinic 1999;15(1):87-96.
  • 5. Geoghegan JM, Forbes J, Clark DI, Smith C, Hubbard R. Dupuytren's disease risk factors. J Hand Surg Br 2004;29(5):423-6.
  • 6. Luck JV. Dupuytren's contracture; a new concept of the pathogenesis correlated with surgical management. J Bone Joint Surg Am 1959:41(4):635-64.
  • 7. Tubiana R. Evaluation of deformities in Dupuytren’s disease. Ann Chir Main 1986;5(1):5-11.
  • 8. McGrouther DA. Dupuytren’s contracture. In: Green’s operative hand surgery. 6th ed. Philadelphia: Elsevier; 2005.159-85.
  • 9. Smith AC. Diagnosis and indications for surgical treatment. Hand Clin. 1991;7(4):635-42.
  • 10. Crean SM, Gerber RA, Graverand MP, Boyd DM, Cappelleri JC. The efficacy and safety of fasciectomy and fasciotomy for Dupuytren’s contracture in European patients: a structured review of published studies. J Hand Surg Eur 2011;36(5):396-407.
  • 11. Desai SS, Hentz VR. The treatment of Dupuytren disease. J Hand Surg Am 2011; 36(5):936-42.
  • 12. Eaton C. Percutaneous fasciotomy for Dupuytren’s contracture. J Hand Surg Am 2011;36(5):910-5.
  • 13. Becker GW, Davis TR. The outcome of surgical treatments for primary Dupuytren’s disease-a systematic review. J Hand Surg Eur 2010;35(8):623-6.
  • 14. Au-Yong IT, Wildin CJ, Dias JJ, Page RE. A review of common practice in Dupuytren surgery. Tech Hand Up Extrem Surg 2005;9(4):178-87.
  • 15. van Rijssen AL, Werker PM. Percutaneous needle fasciotomy in dupuytren's disease. J Hand Surg Br 2006;31(5):498-501.
  • 16. Wilson GR. Current surgical treatment of Dupuytren’s disease. Br J Clin Pract 1997;51(2):106-10.
  • 17. Bryan AS, Ghorbal MS. The long-term results of closed palmar fasciotomy in the management of Dupuytren’s contracture. J Hand Surg Br 1988;13(3):254-6.
  • 18. Foucher G, Medina J, Navarro R. Percutaneous needle aponeurotomy: complications and results. J Hand Surg Br 2003;28(5):427-31.
  • 19. Coert JH, Nérin JP, Meek MF. Results of partial fasciectomy for Dupuytren disease in 261 consecutive patients. Ann Plast Surg 2006;57(1):13-7.
  • 20. Werker PM, Pess GM, van Rijssen AL, Denkler K. Correction of contracture and recurrence rates of Dupuytren contracture following invasive treatment: the importance of clear definitions. J Hand Surg Am 2012;37(10):2095-105.
  • 21. Dias JJ, Braybrooke J. Dupuytren’s contracture: an audit of the outcomes of surgery. J Hand Surg Br 2006;31(5):514-21.
  • 22. Dias JJ, Singh HP, Ullah A, Bhowal B, Thompson JR. Patterns of recontracture after surgical correction of Dupuytren disease. J Hand Surg Am 2013;38(10):1987-93.
  • 23. Tonkin MA, Burke FD, Varian JPW. Dupuytren’s contracture: a comparative study of fasciectomy and dermofasciectomy in one hundred patients. J Hand Surg Br 1984;9(2):156-62.
  • 24. Mäkelä EA, Jaroma H, Harju A, Anttila S, Vainio J. Dupuytren’s contracture: the long-term results after day surgery. J Hand Surg Br 1991;16(3):272-4.
  • 25. Anwar MU, Al Ghazal SK, Boome RS. Results of surgical treatment of Dupuytren’s disease in women: a review of 109 consecutive patients. J Hand Surg Am 2007;32(9):1423-8.
  • 26. Kitridis D, Karamitsou P, Giannaros I, Papadakis N, Sinopidis C, Givissis P. Dupuytren’s disease: limited fasciectomy, night splinting, and hand exercises-long-term results. Eur J Orthop Surg Traumatol 2018;doi:10.1007/s00590-018-2340-6. [Epub ahead of print]
  • 27. Dias JJ, Aziz S. Fasciectomy for Dupuytren Contracture. Hand Clin 2018;34(3):351-66.
  • 28. van Rijssen AL, Gerbrandy FS, Ter Linden H, Klip H, Werker PM. A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren’s disease: a 6-week followup study. J Hand Surg Am 2006;31(5):717-25.
  • 29. Chen NC, Srinivasan RC, Shauver MJ, Chung KC. A systematic review of outcomes of fasciotomy, aponeurotomy, and collagenase treatments for Dupuytren’s contracture. Hand 2011;6(3):250-5.
  • 30. Bryan AS, Ghorbal MS. The long-term results of closed palmar fasciotomy in the management of Dupuytren’s contracture. J Hand Surg Br 1998;13(3):254-6.
  • 31. Moermans JP. Long-term results after segmental aponeurectomy for Dupuytren’s disease. J Hand Surg Br 1996;21(6):797-800.
  • 32. Clibbon JJ, Logan AM. Palmar segmental aponeurectomy for Dupuytren’s disease with metacarpophalangeal fexion contracture. J Hand Surg Br 2001;26(4):360-1.
  • 33. Armstrong JR, Hurren JS, Logan AM. Dermofasciectomy in the management of Dupuytren’s disease. J Bone Joint Surg Br 2000;82(1):90-4.
  • 34. Abbott K, Denney J, Burke FD, McGrouther DA. A review of attitudes to splintage in Dupuytren’s contracture. J Hand Surg Br 1987;12(3):326-8.
Toplam 34 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Konular Ortopedi
Bölüm Özgün Araştırma Makaleleri
Yazarlar

Sercan Çapkın 0000-0001-6957-5927

Tufan Kaleli

Yayımlanma Tarihi 1 Ağustos 2019
Kabul Tarihi 8 Nisan 2019
Yayımlandığı Sayı Yıl 2019

Kaynak Göster

APA Çapkın, S., & Kaleli, T. (2019). Dupuytren Kontraktürü: Parsiyel Fasiektomi Uygulanan 32 Hastanın Retrospektif Analizi. Uludağ Üniversitesi Tıp Fakültesi Dergisi, 45(2), 119-123. https://doi.org/10.32708/uutfd.506471
AMA Çapkın S, Kaleli T. Dupuytren Kontraktürü: Parsiyel Fasiektomi Uygulanan 32 Hastanın Retrospektif Analizi. Uludağ Tıp Derg. Ağustos 2019;45(2):119-123. doi:10.32708/uutfd.506471
Chicago Çapkın, Sercan, ve Tufan Kaleli. “Dupuytren Kontraktürü: Parsiyel Fasiektomi Uygulanan 32 Hastanın Retrospektif Analizi”. Uludağ Üniversitesi Tıp Fakültesi Dergisi 45, sy. 2 (Ağustos 2019): 119-23. https://doi.org/10.32708/uutfd.506471.
EndNote Çapkın S, Kaleli T (01 Ağustos 2019) Dupuytren Kontraktürü: Parsiyel Fasiektomi Uygulanan 32 Hastanın Retrospektif Analizi. Uludağ Üniversitesi Tıp Fakültesi Dergisi 45 2 119–123.
IEEE S. Çapkın ve T. Kaleli, “Dupuytren Kontraktürü: Parsiyel Fasiektomi Uygulanan 32 Hastanın Retrospektif Analizi”, Uludağ Tıp Derg, c. 45, sy. 2, ss. 119–123, 2019, doi: 10.32708/uutfd.506471.
ISNAD Çapkın, Sercan - Kaleli, Tufan. “Dupuytren Kontraktürü: Parsiyel Fasiektomi Uygulanan 32 Hastanın Retrospektif Analizi”. Uludağ Üniversitesi Tıp Fakültesi Dergisi 45/2 (Ağustos 2019), 119-123. https://doi.org/10.32708/uutfd.506471.
JAMA Çapkın S, Kaleli T. Dupuytren Kontraktürü: Parsiyel Fasiektomi Uygulanan 32 Hastanın Retrospektif Analizi. Uludağ Tıp Derg. 2019;45:119–123.
MLA Çapkın, Sercan ve Tufan Kaleli. “Dupuytren Kontraktürü: Parsiyel Fasiektomi Uygulanan 32 Hastanın Retrospektif Analizi”. Uludağ Üniversitesi Tıp Fakültesi Dergisi, c. 45, sy. 2, 2019, ss. 119-23, doi:10.32708/uutfd.506471.
Vancouver Çapkın S, Kaleli T. Dupuytren Kontraktürü: Parsiyel Fasiektomi Uygulanan 32 Hastanın Retrospektif Analizi. Uludağ Tıp Derg. 2019;45(2):119-23.

ISSN: 1300-414X, e-ISSN: 2645-9027

Uludağ Üniversitesi Tıp Fakültesi Dergisi "Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License" ile lisanslanmaktadır.


Creative Commons License
Journal of Uludag University Medical Faculty is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

2023